Asston Pharmaceuticals Ltd — Dividend/Bonus, 04-09-2026: Corp. Action

Asston Pharmaceuticals' board has approved several key corporate actions. This includes appointing M/s Yash A. Jain & Associates as Internal Auditor and M/s Panchal S K & Associates as Statutory Auditors. The board also proposes the re-appointment of Mr. Ashish Narayan Sakalkar as Managing Director, subject to shareholder approval. Additionally, it seeks shareholder approval for proposed remuneration increases for Mr. Sakalkar (MD), Mrs. Saili Jayaram More (WTD & CEO), and Mr. Sachin Chandrakant Badakh (Non-Executive Director). The board also approved the latest Board's Report and the convening of the 7th Annual General Meeting via video conferencing.